CMS Launches Cell and Gene Therapy (CGT) Access Model for Medicaid Sickle Cell Patients
What You Should Know:
– The Centers for Medicare & Medicaid Services (CMS) launches its Cell and Gene Therapy (CGT) Access Model, a new approach to delivering cutting-edge treatments for people on Medicaid living with…
Continue Reading